Marijuana, absinthe and the central nervous system
- PMID: 1110781
- DOI: 10.1038/253365a0
Marijuana, absinthe and the central nervous system
Similar articles
-
Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa.Psychopharmacologia. 1970 Aug 19;18(1):82-93. doi: 10.1007/BF00402387. Psychopharmacologia. 1970. PMID: 5535578 No abstract available.
-
Reproductive and teratologic studies with delta9-tetrahydrocannabinol and crude marijuana extract.Toxicol Appl Pharmacol. 1976 Nov;38(2):223-35. doi: 10.1016/0041-008x(76)90131-9. Toxicol Appl Pharmacol. 1976. PMID: 996857 No abstract available.
-
Cannabis sativa L. (marijuana). V. Pharmacological evaluation of marijuana aqueous extract and volatile oil.J Pharm Sci. 1974 Jun;63(6):962-4. doi: 10.1002/jps.2600630640. J Pharm Sci. 1974. PMID: 4850869 No abstract available.
-
Adverse health effects of non-medical cannabis use.Lancet. 2009 Oct 17;374(9698):1383-91. doi: 10.1016/S0140-6736(09)61037-0. Lancet. 2009. PMID: 19837255 Review.
-
Chemistry and pharmacology of marijuana.J Pharm Sci. 1971 Oct;60(10):1433-57. doi: 10.1002/jps.2600601002. J Pharm Sci. 1971. PMID: 4942969 Review. No abstract available.
Cited by
-
Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification.Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):3826-31. doi: 10.1073/pnas.070042397. Proc Natl Acad Sci U S A. 2000. PMID: 10725394 Free PMC article.
-
Absinthism: a fictitious 19th century syndrome with present impact.Subst Abuse Treat Prev Policy. 2006 May 10;1:14. doi: 10.1186/1747-597X-1-14. Subst Abuse Treat Prev Policy. 2006. PMID: 16722551 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources